| TGA Action ID |
RC-2026-RN-00826-1 |
| Type of Product |
Medical Device |
| Product Name/Description |
Libre App
Version: 1.4.0 & 1.4.1 |
| ARTG Number |
363331 |
| Unique Device Identifier (UDI) |
05021791010233, 05021791010240 |
| Action Type |
Product Correction |
| Action Level |
Consumer |
| Hazard Classification |
Class II |
| Reason for the Action |
Abbott has identified a potential security vulnerability affecting the Libre app.
This problem could only be activated by someone in close proximity to a person’s device and cannot be activated remotely over the internet.
As of 9-Oct-2026, Abbott is not aware of any unauthorised access to a patient's app in relation to this vulnerability, and there have been no reports of adverse events.
In the unlikely event that this vulnerability were to be exploited, the apps could display incorrect sensor glucose readings, and alarms may not function as intended or may provide incorrect alerts, which may lead people with diabetes to make inappropriate treatment decisions, such as taking too much or too little insulin or delaying necessary treatment.
This event pertains to the Libre App only.
20/10/26: Abbott issued an app security update for the Libre app on 16/10/26. Since then, Abbott found that this update may cause some users to experience extended signal loss, meaning their sensor loses connection with the app and doesn’t reconnect. If this happens, a user app may not receive glucose readings, which may lead to missed alarms and/or treatment decisions.
Abbott is not aware of any unauthorised access related to this vulnerability. |
| Instructions for Customers/Users |
A software update (version starts with 1.4.1) has been released.
- Check the current app version and immediately update the Libre app to the latest version starting with 1.4.1. - If the current app version starts with 1.4.1 no further actions are required.
20/10/26: Customers will be notified as soon as a new app update is available.
Follow the detailed instructions in the updated Customer Letter which supersedes previous instructions (above). Libre app version that starts with 1.4.0 – Wait for Abbott to inform you when the new app is ready to download.
Libre app version that starts with 1.4.1 - Most people will continue to receive their glucose readings and alarms as usual. Abbott advises that you can keep using your app and sensor but be aware that you may experience extended signal loss.
Until a new version of the app is available, if you experience extended signal loss, please follow the troubleshooting tips on www.LibreCheck.com/en-au for help reconnecting your app and sensor or contact Libre Customer Care. You do not need to remove or replace your sensor.
22/10/26: The updated app (v 1.4.2) is now available that addresses both problems. Follow the customer letter for instructions on how to download the update.
Abbott advises that if symptoms do not match the sensor reading, or you think the reading might be off, check the reading by conducting a fingerpick test using a blood glucose meter. |
| Action Commencement Date |
14/10/2026 |
| Responsible Entity |
|
| Contact Information |
1800 801 478 - FreeStyle Libre Customer Care |